Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
PHASE3
This phase III trial compares the effect of adding cabozantinib to avelumab...
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
N/A
Genetic mutations have closely linked to the pathogenesis and prognosticati...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2019-08-19
Trial ID
NCT04060485
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
PHASE2
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...